Internal Medicine, Medical Oncology · Philadelphia, PA
NPI
1457745689
Since 2015
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3400 Civic Center Boulevard
Philadelphia, PA, 19104
Phone (215) 220-9578
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
802 services
Medicare patients, 2024
200
Average age 73
Drug cost, 2024
$1.8M
388 prescriptions
Company payments, 2025
$2,209
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Igor Makhlin was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 205 times for 103 patients. In total Igor Makhlin billed 802 services in 11 codes, and Medicare paid $46K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 205 | 103 | $13.26 | $2,719 |
| 99214 Office E&M - Established | Office | 165 | 88 | $69.56 | $11K |
| 99215 Office E&M - Established | Office | 85 | 46 | $113.19 | $9,621 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 74 | 58 | $13.33 | $986 |
| 99214 Office E&M - Established | Facility | 72 | 46 | $68.11 | $4,904 |
| 99232 Hospital E&M - Subsequent | Facility | 43 | 18 | $63.51 | $2,731 |
| 99215 Office E&M - Established | Facility | 42 | 30 | $108.34 | $4,550 |
| 99213 Office E&M - Established | Office | 35 | 27 | $52.33 | $1,832 |
| 99205 Office E&M - New | Office | 22 | 22 | $147.15 | $3,237 |
| 99213 Office E&M - Established | Facility | 20 | 16 | $53.37 | $1,067 |
| 99205 Office E&M - New | Facility | 12 | 12 | $135.09 | $1,621 |
By year: 2022 $22K for 249 services; 2023 $32K for 363 services; 2024 $46K for 802 services.
Medicare prescription drug claims, 2024
In 2024, the drug Igor Makhlin prescribed most often to Medicare patients was Letrozole, with 116 prescriptions and refills. In total Igor Makhlin wrote 388 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 116 | 340 | 48 | $2,791 |
| Exemestane Generic | 57 | 113 | 16 | $11K |
| Truqap Capivasertib | 54 | 54 | 11 | $1.2M |
| Tamoxifen Citrate Generic | 25 | 59 | Under 11 | $592 |
| Anastrozole Generic | 24 | 70 | Under 11 | $405 |
| Ibrance Palbociclib | 15 | 15 | Under 11 | $237K |
| Kisqali Ribociclib Succinate | 11 | 11 | Under 11 | $181K |
Brand drugs: 99 claims; generic drugs: 289 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Igor Makhlin $2,209 ($2,209 in general payments such as food, travel and fees) from 4 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,700.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.